Latest Virosome Stories
In-license Vaccine Technology for Respiratory Syncytial Virus (RSV) from Mymetics TOKYO, ROCKVILLE, Md. and EPALINGES, Switzerland, Jan.
BERNE, Switzerland, April 21, 2011 /PRNewswire/ -- Pevion Biotech AG today announced that Jean-Paul Prieels has joined its Board of Directors. Until January 2011, Dr.
ITTIGEN, Switzerland and BERN, Switzerland, February 10, 2011 /PRNewswire/ -- Pevion Biotech Ltd. today announced the appointment of Didier Hoch as Chairman of its Board of Directors.
ITTIGEN and BERN, Switzerland, November 11, 2010 /PRNewswire/ -- Pevion Biotech AG today announced positive preliminary results from a Phase I study of PEV7, the first vaccine against recurrent vulvovaginal candidiasis (RVVC). Also known as chronic recurrent thrush, RVVC is a highly debilitating condition, which affects an estimated 3-6% of women worldwide.
BERNE, Switzerland, September 7, 2010 /PRNewswire/ -- Pevion Biotech AG announced today the appointment of Evert Kueppers as its new Chief Executive Officer, succeeding Thomas Stauffer. "We would like to thank Thomas for his excellent contributions over the years and wish him all the best in his new position," said Klaus Breiner of BB Biotech Ventures and Chairman of the Board of Directors.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.